SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: scots40 who wrote (4582)8/4/2010 1:51:24 PM
From: Ian@SI  Read Replies (2) | Respond to of 4676
 
I heard the CEO being interviewed on CNBC. He believes the problem is manageable. Sounds like there may be a chance that it gets approved as a last line of defense for those with the worst cases of hyperlipedemia.

But the chance of it ever making it to the general cholesterol management market sounds remote to me.

I'm not competent to call that shot neither.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News